<! –

->

<img src = "http://teletechwire.com/wp-content/uploads/logos/Logos/ENDP.png" alt = "Endo International plc ( NASDAQ: ENDP) Logo "title =" Endo International plc (NASDAQ: ENDP) Logo "style =" float: on the left, investor confidence decreased to 1.07 in 2018 in the first quarter, down 0.06 compared with 1.13 in the fourth quarter of 2017. It has worsened, 25 investors selling shares of Endo International plc and 70 having narrowed their positions .. increase in holdings: 213.17 million; shares or 4.61% more against 203.77 million shares in the fourth quarter 2017.
Dimensional Fund Advsr LP holds 10.72 million shares and Hsbc Holdings Limited Limited invested 0% in Endo International plc (Nasdaq: ENDP) Pnc Svcs Inc. holds 844 shares for 0% of its portfolio, State Street has accumulated 0% or 7.31 million shares, Tci Wealth Ad vsrs invested 0.04% or 15,077 shares and Stifel Fincl Corp 16,692 shares, or 0% of its portfolio. holds 0% or 10,287 securities in its portfolio, of which 305,456 were reported by Barclays Public Ltd. Comerica Retail Bank has invested 0.01% in Endo International plc (Nasdaq: ENDP), Deutsche Bankshares Ag has declared 2.80 million shares and Citadel Advsrs Ltd acquires 0% of its portfolio in Endo International plc (NASDAQ : ENDP). Kbc Grp Nv holds 249,531 shares, representing 0.01% of its portfolio. Price T Rowe Assoc Md holds 0% or 82,112 shares. Voya Mngmt Lc has invested 0% of its portfolio in Endo International plc (NASDAQ: ENDP). Riverhead Mgmt Llc, a Delaware-based fund reported 41,218 shares.

Analysts expect Endo International plc (NASDAQ: ENDP) to announce $ 0.54 EPS on August 14. The benefit of the ENDP would be $ 120.83 million, or 5.16 P / E if the $ 0.54 EPS is correct. After previously recording earnings per share of $ 0.67, badysts at Endo International plc posted earnings per share growth of -19.40%. The stock fell 0.62% or $ 0.07 during the last trading session, reaching $ 11.15. About 1.83 million shares traded. Endo International plc (NASDAQ: ENDP) has fallen 51.05% since July 22, 2017 and is down. It underperformed the S & P500 by 63.62%.

Endo International plc (NASDAQ: ENDP) Coverage of ratings

Among 9 badysts covering Endo International (NASDAQ: ENDP), 2 have Buy, 0 Sell and 7 Hold ratings. As a result, 22% are positive. Endo International had 10 badyst reports since February 13, 2018 according to SRatingsIntel. The company received JMP Securities' Market Perform rating on Monday, February 26th. The title of Endo International plc (Nasdaq: ENDP) was rated "Equal-Weight" on Friday, February 23rd by Barclays Capital. FBR Capital maintained the Endo International plc rating (NASDAQ: ENDP) on Thursday, June 28th. FBR Capital has a "Buy" rating and a $ 13 target. Citigroup has updated the shares of the ENDP in the report of Wednesday, June 27 to the "Buy" rating. The rating was lowered by Mizuho to "Neutral" on Wednesday, April 4th. The rating was maintained by William Blair with "Hold" on Wednesday, February 28th. The Endo International plc share (NASDAQ: ENDP) has "Market Perform" given on Monday, March 5th by BMO Capital Markets. The title of Endo International plc (Nasdaq: ENDP) got the note "Hold" on Wednesday February 28th by Gabelli. Canaccord Genuity maintained the shares of ENDP in its report on Wednesday, February 21 with the "Hold" rating. FBR Capital initiated the shares of ENDP in its report of Tuesday, February 13 with the note "Buy"

Endo International plc develops, manufactures and distributes pharmaceutical products and devices worldwide. The company has a market capitalization of $ 2.50 billion. The US company It currently has negative profits. The generic pharmaceutical segment provides tablets, capsules, powders, injectables, liquids, nasal, ophthalmic and transdermal sprays for the management of pain, urology, central nervous system disorders, immunosuppression, Oncology, Women's Health and Cardiovascular Disease

and important news Endo International plc (NASDAQ: ENDP) was published by Benzinga.com which published an article entitled: "Endo wins Citi Upgrade on Positive Catalysts , Opportunity of Cellulite Treatment "June 27, 2018.

– Enter your email address below to receive a daily concise summary of the latest news and badyst insights with our FREE Daily Email.